61
13
10
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0223 |
Lusutrombopag
芦曲泊帕,鲁索曲波帕,S-888711,Mulpleta |
Thrombin; Thrombopoietin Receptor | Immunology/Inflammation; Proteases/Proteasome |
Lusutrombopag (Mulpleta) 是一种口服生物可利用的小分子血小板生成素 (TPO) 受体激动剂,用于选择性侵入性手术前患有血小板减少症的慢性肝病的患者。 | |||
T6825 |
Eltrombopag Olamine
Promacta Olamine,Revolade,艾曲泊帕乙醇胺盐,Eltrombopag diethanolamine salt,SB497115,艾曲波帕乙醇胺盐,SB-497115GR |
Thrombin | Proteases/Proteasome |
Eltrombopag Olamine (Eltrombopag diethanolamine salt) 是 Eltrombopag 的口服活性乙醇胺盐,是一种血小板生成素(TPO)受体激动剂,用于血小板减少的某些病症研究。 | |||
T4635 |
Ralinepag
APD811 |
Others; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Others |
Ralinepag (APD811) 是一种可口服的非前列腺素前列环素 (IP) 受体激动剂,对人和大鼠 IP 受体以及人 DP1 受体的 EC50 分别为 8.5、530 和 850 nM。 | |||
T4460 |
Dapagliflozin ((2S)-1,2-propanediol, hydrate)
BMS-512148 (2S)-1,2-propanediol, hydrate,达格列净 (2S)-1,2-丙二醇水合物,Dapagliflozin propanediol monohydrate |
SGLT | GPCR/G Protein |
Dapagliflozin ((2S)-1,2-propanediol, hydrate) (BMS-512148 (2S)-1,2-propanediol, hydrate) 是 Dapagliflozin 1,2-propanediol, hydrate 的 S 型异构体,是竞争性葡萄糖协同转运蛋白2 抑制剂,可促进尿液中葡萄糖的排泄,可用于糖尿病的研究。它诱导 HIF1表达并减轻肾脏 IR 损伤。 | |||
T2389 |
Dapagliflozin
达格列净,BMS-512148 |
SGLT; HIF | Angiogenesis; Chromatin/Epigenetic; GPCR/G Protein |
Dapagliflozin (BMS-512148) 竞争性的葡萄糖协同转运蛋白2 (SGLT2) 抑制剂,可促进尿液中葡萄糖的排泄,在糖尿病 (DM) 研究中具有价值。Dapagliflozin 诱导 HIF1表达并减轻肾脏 IR 损伤。 | |||
T15273 |
Fedovapagon
VA483,A106483 |
Vasopressin Receptor | GPCR/G Protein |
Fedovapagon (VA106483) 是一种具有选择性和高效性的加压素 V2 受体 (V2R) 激动剂,可抑制斑马鱼节间血管的生长。Fedovapagon 可用于研究膀胱过度活动症、夜尿症和膀胱疼痛综合征。 | |||
T7417 |
Avatrombopag
YM477,AKR-501,1-[3-氯-5-[[[4-(4-氯-2-噻吩基)-5-(4-环己基-1-哌嗪基)-2-噻唑基]氨基]羰基]-2-吡啶基]-4-哌啶羧酸,E5501 |
Thrombin; Thrombopoietin Receptor | Immunology/Inflammation; Proteases/Proteasome |
Avatrombopag (YM477) 是一种新型口服血小板生成素 (TPO) 受体激动剂,可激活 TPO 受体并增加巨核细胞增殖/分化和血小板生成。 | |||
T20641 |
Propagermanium
Dipropanoic acid germanium sequioxide,SK-818,Ge 132,二羧乙基三氧化二锗,Ge132,SK 818,Ge-132 |
Others | Others |
Propagermanium (Ge132) 是一种锗的有机金属化合物,在日本已被用作治疗慢性乙型肝炎的药物。 | |||
T22870 |
IPAG
|
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
IPAG 是有效的 sigma-1 受体拮抗剂 (pKi= 4.3)。 IPAG 可诱导细胞凋亡。 | |||
T3174 |
Taprenepag
CP-544326 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Taprenepag (CP-544326) 是一种有效的选择性前列腺素 E2 受体激动剂,EC50为 2.8 nM,可用于研究开角治疗高眼压和青光眼的试验。 | |||
T15259 |
Evatanepag
CP-533536 free acid,2-[3-[N-(4-叔丁基苄基)-N-(吡啶-3-基磺酰基)氨基甲基]苯氧基]乙酸 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Evatanepag (CP-533536 free acid) 是一种 EP2 受体选择性前列腺素 E2 (PGE2) 激动剂,可诱导局部骨形成,EC50 为 0.3 nM。它在大鼠骨折愈合模型中以单剂量局部给药时表现出愈合骨折的能力。 | |||
T1766 |
Empagliflozin
BI 10773,恩格列净 |
SGLT | GPCR/G Protein |
Empagliflozin (BI 10773) 是一种 SGLT-2 抑制剂 (IC50=3.1 nM),具有有效的和选择性,对 SGLT-1/4/5/6 的选择性高 300 倍以上。Empagliflozin 可用于治疗二型糖尿病。 | |||
T6750 |
Opaganib
ABC294640 |
S1P Receptor | GPCR/G Protein |
Opaganib (ABC294640) 是选择性和竞争性的鞘氨醇激酶 2 (SK2) 抑制剂,Ki 为 9.8 μM。 | |||
T67849 |
O-Desethyl Dapagliflozin
Empagliflozin-4 |
SGLT | GPCR/G Protein |
O-Desethyl Dapagliflozin (Empagliflozin-4) 是一种 SGLT2 抑制剂, IC50=33nM. | |||
T3216 |
Selexipag
NS-304,ACT-293987,赛乐西帕,Uptravi |
Others; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Others |
Selexipag (ACT-293987) 是前列环素受体激动剂,可引起肺血管舒张,用于治疗肺动脉高压。 | |||
T1088 |
Repaglinide
AG-EE 388 ZW,AG-EE 623ZW,瑞格列奈 |
Potassium Channel; PPAR | DNA Damage/DNA Repair; Membrane transporter/Ion channel; Metabolism |
Repaglinide (AG-EE 623ZW) 是一种能够用于2 型糖尿病的胰岛素促分泌剂。 | |||
T2562 |
Eltrombopag
SB-497115,SB-497115-GR,艾曲波帕 |
Thrombin | Proteases/Proteasome |
Eltrombopag (SB-497115-GR) 是一种具有巨核细胞生成刺激活性的口服活性血小板生成素受体激动剂,可结合并刺激血小板血小板生成素受体,用于血小板减少的某些病症研究。 | |||
T76822 | Pagibaximab | ||
Pagibaximab为一种嵌合IgG1抗体,针对金黄色葡萄球菌与表皮链球菌的表面脂肪酸成分具有特异性识别能力。其主要应用于预防葡萄球菌所引起的败血症。 | |||
T10957 |
Dapagliflozin impurity
|
Others | Others |
Dapagliflozin impurity is the enantiomer of Dapagliflozin, Dapagliflozin is a sodium glucose transporter 2 inhibitor. | |||
T124813 |
N-Methylsarpagine methosalt
|
||
N-Methylsarpagine methosalt 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T124813。 | |||
T62864 |
Hetrombopag
|
||
Hetrombopag 是一种 thrombopoietin receptor 的有效激动剂。Hetrombopag 具有良好的耐受性且安全性可控。Hetrombopag 具有潜力进行免疫性血小板减少症的研究。 | |||
T126029 |
8-cis-Cinnamoylharpagide
|
||
8-cis-Cinnamoylharpagide 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T126029,CAS号为 133645-36-0。 | |||
T68888 |
Avatrombopag maleate
|
||
Avatrombopag, also known as AKR-501, YM477, AS 1670542 or E5501, is a novel orally-active thrombopoietin (TPO) receptor agonist. AKR-501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR-501 may be useful in the treatment of patients with thrombocytopenia. Avatrombopag was first approved in 2018. | |||
T27536 |
Hetrombopag olamine
|
||
Hetrombopag olamine is a non-peptide thrombopoietin (TPO) receptor agonist with oral activity. | |||
T61876 | Sipagladenant | ||
Sipagladenant (Compound I) is an orally active inverse agonist targeting the adenosine receptor A2A [1]. It possesses potential for utilization in research pertaining to frontal lobe dysfunction [2]. | |||
T69755 |
Evatanepag sodium
|
||
Evatanepag, also known as CP-533536, is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation. CP-533536 demonstrated the ability to heal fractures when administered locally as a single dose in rat models of fracture healing. | |||
T124431 |
Pagoside
|
||
TQ0285L |
Spaglumic acid acetate
Isospaglumic acid acetate,Spaglumic acid acetate(3106-85-2 Free base) |
Endogenous Metabolite | Metabolism |
Spaglumic acid acetate (Isospaglumic acid acetate) 是一种在脑中以毫摩尔浓度存在的神经肽。 | |||
TMIH-0013 |
(S)-Empagliflozin-d4
|
||
(S)-Empagliflozin-d4 是 (S)-Empagliflozin 的氘代化合物。(S)-Empagliflozin 的 CAS 号为 864070-44-0。Empagliflozin 是有效的、选择性的钠葡萄糖协同转运蛋白-2 (SGLT-2) 抑制剂,对人 SGLT-2 的IC50为 3.1 nM。 | |||
T19548 |
Repaglinide D5
AG-EE 623ZW D5,瑞格列奈 D5 |
Others | Others |
Repaglinide D5 is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for treatment type-2 diabetes mellitus. | |||
T64615 | EMpagliflozin iMpurity 5 | ||
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-hydroxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T64615。 | |||
T71301 | Opaganib HCl | ||
ABC294640, also known as Opaganib, is an orally available, aryladamantane compound and selective inhibitor of sphingosine kinase-2 (SK2) with potential antineoplastic activity. Upon administration, ABC294640 competitively binds to and inhibits SK2, thereby preventing the phosphorylation of the pro-apoptotic amino alcohol sphingosine to sphingosine 1-phosphate (S1P), the lipid mediator that is pro-survival and critical for immunomodulation. This may eventually lead to the induction of apoptosis a... | |||
T25547 |
Isospaglumate sodium
Isospaglumate trisodium,Sodium isospaglumate |
||
Isospaglumate sodium is the sodium salt of isospaglumate which is an antiallergic agent. | |||
T62865 |
Rafutrombopag
|
||
Rafutrombopag 是一种血小板生成素 (TPO) 激动剂。 | |||
T29708 |
Aganepag isopropyl
AGN-210961,AGN 210961,AGN210961 |
||
Aganepag isopropyl can be used to treat Glaucoma. | |||
T68560 |
Totrombopag choline
|
||
Totrombopag, also known LGD-4665, GSK2285921 and SB559448, is an oral thromobopoietin receptor agonist, is being developed as a new generation small molecule thrombopoietin (TPO) mimetic. It is a highly selective and potent agonist of the TPO receptor and therefore induces differentiation and proliferation of megakaryocytes. The pharmacologic characteristics indicate potential therapeutic use in thrombocytopenic patients with a variety of clinical etiologies. | |||
T67184 |
PeracetylEmpagliflozin
|
||
(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T67184。 | |||
T13497 |
3'-Hydroxy Repaglinide
|
Others | Others |
3'-Hydroxy Repaglinide is a main CYP2C8 metabolite of Repaglinide. Repaglinide is a carbamoylmethyl benzoic acid derivative and used as the treatment of type II diabetes. | |||
T14139 |
Aganepag
AGN 210937 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Aganepag, a potent Prostanoid EP2 receptor agonist, exhibits remarkable selectivity with an EC50 of 0.19 nM, demonstrating no activity at the EP4 receptor. Its applications are primarily in the fields of wound healing, scar reduction, scar prevention, and the treatment and prevention of wrinkles. | |||
TMIH-0520 |
Selexipag-d7
|
||
Selexipag-d7 是 Selexipag 的氘代化合物。Selexipag 的 CAS 号为 475086-01-2。Selexipag 是前列环素受体激动剂,可引起肺血管舒张,用于治疗肺动脉高压。 | |||
T64667 | 10× SDS-PAGE SDS Running Buffer | Others | Others |
10× SDS-PAGE SDS Running Buffer 是 SDS-PAGE (SDS-变性聚丙烯酰胺凝胶电泳) 10 倍浓缩的缓冲液,主要成分为三羟甲基氨基甲烷(Tris)、甘氨酸(Glycine)和十二烷基硫酸钠(SDS)。 | |||
T40654 |
Avatrombopag hydrochloride
AKR-501 hydrochloride,YM477hydrochloride,E5501hydrochloride |
||
Avatrombopag hydrochloride (AKR-501) is an orally active, nonpeptide agonist of the thrombopoietin (TPO) receptor with an EC 50 of 3.3 nM. It effectively mimics the biological activities of TPO, stimulating platelet production by activating the intracellular signaling system and facilitating the generation of platelets and megakaryocytes from hemopoietic precursor cells. Additionally, Avatrombopag hydrochloride serves as a substrate for cytochrome P450 (CYP) 2C9 and CYP3A. | |||
T16988 |
Taprenepag isopropyl
PF-04217329 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Taprenepag isopropyl is a highly selective agonist of the EP2 receptor. | |||
T35619 |
Dapagliflozin-3-O-β-D-Glucuronide
|
||
Dapagliflozin-3-O-β-D-glucuronide is a metabolite of dapagliflozin . Dapagliflozin is a first generation selective sodium glucose cotransporter (SGLT) 2 inhibitor that blocks glucose transport.[1] Dapagliflozin is metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A9 to dapagliflozin-3-O-β-D-glucuronide, which is 2,600-fold less potent than the parent compound with regard to SGLT2 inhibition.[2] | |||
T79850 |
Irpagratinib
ABSK011 |
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Irpagratinib (ABSK011)是一种靶向FGFR4(IC50<10 nM)的口服活性酪氨酸激酶抑制剂,可抑制FGFR4自磷酸化并阻断其信号转导至下游途径。在小鼠、大鼠和狗的PK研究中,Irpagratinib表现出高暴露量,并在皮下异种移植肿瘤模型中展示抗肿瘤活性。 | |||
T29707 |
Aganepag ethanediol
AGN-212409,AGN212409 |
||
Aganepag ethanediol 是一种降低眼压的抗青光眼化合物。Aganepag ethanediol 是一种选择性 EP2 受体激动剂。 | |||
TMIH-0045 |
3-Hydroxy Repaglinide-d5
|
||
3-Hydroxy Repaglinide-d5 是 3-Hydroxy Repaglinide 的氘代化合物。 | |||
TMIH-0519 |
Selexipag Active Metabolite-d7
|
||
Selexipag Active Metabolite-d7 是 Selexipag Active Metabolite 的氘代化合物。Selexipag Active Metabolite 的 CAS 号为 475085-57-5。MRE269 是一种口服的长效前列环素受体激动剂前药,是 Selexipag 的活性代谢物,用于治疗肺动脉高压。 | |||
T126028 | 8-O-4-Hydroxycinnamoylharpagide | ||
8-O-4-Hydroxycinnamoylharpagide 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T126028,CAS号为 133645-37-1。 | |||
T34644 |
Simenepag isopropyl
AGN210669,AGN-210669,AGN 210669 |
||
Simenepag isopropyl can be used for the treatment of Glaucoma, Ocular Hypertension. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0285 |
Spaglumic acid
异冬谷酸,N-Acetylaspartylglutamic acid,NAAG |
Endogenous Metabolite | Metabolism |
Spaglumic acid (N-Acetylaspartylglutamic acid) 是一种神经肽,在脑中以毫摩尔浓度存在。 | |||
T6S2025 |
8-O-Acetylharpagide
8-O-乙酰哈巴苷,8-Acetylharpagide,3-Acetylharpagide,Acetylharpagide,8-O-Acetylharpagide |
Antibacterial | Microbiology/Virology |
8-O-Acetylharpagide 是从 Ajuga reptans 中分离得到的一种环烯醚萜,有抗肿瘤、抗病毒、抗菌和抗炎作用。它对豚鼠的离体平滑肌有生物活性。 | |||
T6S2024 |
Harpagide
|
Antibacterial; Parasite | Microbiology/Virology |
Harpagide 是从Scrophularia cryptophila 中分离出来的一种鸢尾糖苷,具有抗炎和抗寄生虫活性,对T.b. rhodesiense 具有体外锥虫杀虫活性,IC50为 21 μg/mL,它对L. donovani 的IC50值为 2.0 μg/mL。 | |||
T6S2023 |
Harpagoside
|
Others; COX; NO Synthase | Immunology/Inflammation; Neuroscience; Others |
Harpagoside 是从爪钩草中分离出来的一种天然产物,可抑制COX-1和COX-2活性,并抑制 NO 的产生。 | |||
T74202 |
Hispaglabridin A
|
||
Hispaglabridin A 是一种抗氧化剂,可有效防止脂质过氧化。 | |||
TN4034 |
Eupaglehnin C
|
Others | Others |
Eupaglehnin C shows cytotoxic (2.19 mg/ml) against HeLa-S3. | |||
TN3162 | 6-Epi-8-O-acetylharpagide | Others | Others |
6-Epi-8-O-acetylharpagide是一种天然产物,属于玄参科玄参属,其产品编号为 TN3162,CAS号为 97169-44-3。6-Epi-8-O-acetylharpagide可用作对照参考。 | |||
TN1321 |
6'-O-Cinnamoyl harpagide
6'-O-Cinnamoylharpagide,(1S,4AS,5R,7S,7AR)-1,4A,5,6,7,7A-六氢-4A,5,7-三羟基-7-甲基环戊二烯并[C]吡喃-1-基 BETA-D-吡喃葡萄糖苷 6-[(2E)-3-苯基-2-丙烯酸酯],6'-O-肉桂酰基哈巴苷,6'-O-肉桂酰哈巴苷 |
Others | Others |
6'-O-Cinnamoylharpagide has anti-inflammatory activity. | |||
T20617 |
Sarpagine
Raupin |
||
Sarpagine is an alkaloid with the antihypertonic effect. | |||
TN2953 |
3-Hydroxysarpagine
|
Topoisomerase | DNA Damage/DNA Repair |
3-Hydroxysarpagine是一种天然产物,属于夹竹桃科萝芙木属,其产品编号为 TN2953,CAS号为 857297-90-6。3-Hydroxysarpagine可用作对照参考。 | |||
TN3167 | 6-Epiharpagoside | Others | Others |
6-Epiharpagoside 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN3167,CAS号为 1151862-67-7。 | |||
TN3166 |
6-Epiharpagide
|
Others | Others |
6-Epiharpagide is a natural product from Scrophularia ningpoensis Hemsl. | |||
T2S1749 |
Protogracillin
原纤细薯蓣皂甙 |
Others | Others |
Protogracillin 是一种甾体皂苷,分离自Dioscorea zingiberensisWright (DZW) 中。从 DZW 根状茎中获得的甾体皂苷具有抗血栓作用,同时由降低心血管疾病风险的潜力。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-00293 |
PAG-1 Protein, Bovine, Recombinant (His)
|
Bovine | E. coli |
Appears to be proteolytically inactive. PAG-1 Protein, Bovine, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 40.7 kDa and the accession number is Q29432. | |||
TMPH-00295 |
PAG-2 Protein, Bovine, Recombinant (His)
|
Bovine | E. coli |
PAG2 or a processed derivative of this molecule might represent a factor that binds the LH receptor. PAG-2 Protein, Bovine, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 43.6 kDa and the accession number is Q28057. | |||
TMPH-00294 |
PAG-1 Protein, Bovine, Recombinant (His & SUMOstar)
|
Bovine | P. pastoris (Yeast) |
Appears to be proteolytically inactive. PAG-1 Protein, Bovine, Recombinant (His & SUMOstar) is expressed in yeast with N-6xHis-sumostar tag. The predicted molecular weight is 49.8 kDa and the accession number is Q29432. | |||
TMPY-01276 |
Peroxiredoxin 1 Protein, Human, Recombinant (His)
PAGA,peroxiredoxin 1,NKEFA,MSP23,PAG,TDPX2... |
Human | E. coli |
Peroxiredoxin 1 Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 22.9 kDa and the accession number is A0A384NPQ2. | |||
TMPY-02372 |
Peroxiredoxin 1 Protein, Mouse, Recombinant (His)
PAG,OSF-3,OSF3,Paga,PRDX1,Tdpx2,PrxI,TDX2,... |
Mouse | E. coli |
Peroxiredoxin 1 Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 23.5 kDa and the accession number is P35700. | |||
TMPH-03081 |
ACE2 Protein, Paguma larvata, Recombinant (hFc)
EC:3.4.17.23,Angiotensin-converting enzyme 2,ACE-related car... |
Paguma larvata | HEK293 Cells |
ACE2 Protein, Paguma larvata, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-hFc tag. The predicted molecular weight is 112.7 kDa and the accession number is Q56NL1. | |||
TMPH-00743 |
PhoP Protein, E. coli, Recombinant (HEK293, His & Myc)
|
E. coli | HEK293 Cells |
Member of the two-component regulatory system PhoP/PhoQ involved in adaptation to low Mg(2+) environments and the control of acid resistance genes. In low periplasmic Mg(2+), PhoQ phosphorylates PhoP, resulting in the expression of PhoP-activated genes (PAG) and repression of PhoP-repressed genes (PRG). In high periplasmic Mg(2+), PhoQ dephosphorylates phospho-PhoP, resulting in the repression of PAG and may lead to expression of some PRG. Mediates magnesium influx to the cytosol by activation o... | |||
TMPK-00556 |
BTN3A1 Protein, Cynomolgus, Recombinant (His & Avi)
BTN3.1,CD277,BTF5,BT3.1,BTN3A1 |
Cynomolgus | HEK293 Cells |
The three butyrophilin BTN3A molecules, BTN3A1, BTN3A2, and BTN3A3, are members of the B7/butyrophilin-like group of Ig superfamily receptors, which modulate the function of T cells. BTN3A1 controls activation of human Vγ9/Vδ2 T cells by direct or indirect presentation of self and nonself phosphoantigens (pAg). BTN3A1 Protein, Cynomolgus, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 26.5 kDa and the accession number is A0A33... | |||
TMPK-00310 |
BTN3A1 Protein, Human, Recombinant (His & Avi), Biotinylated
CD277,BTN3A1,BTF5,BT3.1,BTN3.1 |
Human | HEK293 Cells |
The three butyrophilin BTN3A molecules, BTN3A1, BTN3A2, and BTN3A3, are members of the B7/butyrophilin-like group of Ig superfamily receptors, which modulate the function of T cells. BTN3A1 controls activation of human Vγ9/Vδ2 T cells by direct or indirect presentation of self and nonself phosphoantigens (pAg). BTN3A1 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 27.1 kDa and the accession number... | |||
TMPK-00557 |
BTN3A1 Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated
BTF5,BT3.1,BTN3.1,CD277,BTN3A1 |
Cynomolgus | HEK293 Cells |
The three butyrophilin BTN3A molecules, BTN3A1, BTN3A2, and BTN3A3, are members of the B7/butyrophilin-like group of Ig superfamily receptors, which modulate the function of T cells. BTN3A1 controls activation of human Vγ9/Vδ2 T cells by direct or indirect presentation of self and nonself phosphoantigens (pAg). BTN3A1 Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 26.5 kDa and the accession n... |